Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
| Author | |
|---|---|
| Abstract |
:
The cost-effectiveness of population-based panel testing for high- and moderate-penetrance ovarian cancer (OC)/breast cancer (BC) gene mutations is unknown. We evaluate the cost-effectiveness of population-based BRCA1/BRCA2/RAD51C/RAD51D/BRIP1/PALB2 mutation testing compared with clinical criteria/family history (FH) testing in unselected general population women. |
| Year of Publication |
:
2018
|
| Journal |
:
Journal of the National Cancer Institute
|
| Date Published |
:
2018
|
| ISSN Number |
:
0027-8874
|
| URL |
:
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnci/djx265
|
| DOI |
:
10.1093/jnci/djx265
|
| Short Title |
:
J Natl Cancer Inst
|
| Download citation |
